Vastarel XR

Vastarel XR

trimetazidine

Manufacturer:

Servier

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Trimetazidine diHCl
Indications/Uses
Add-on therapy for symptomatic treatment of adults w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line antianginal therapies.
Dosage/Direction for Use
Administration
Should be taken with food: Take during meals. Swallow whole, do not open cap.
Contraindications
Hypersensitivity. Parkinson disease, Parkinsonian symptoms, tremors, restless leg syndrome & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Not a curative treatment for angina attacks or as initial treatment for unstable angina, MI, pre-hospital phase or during 1st days of hospitalisation. Discontinue use if movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, gait instability occur. Falls related to gait instability or hypotension. Fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency. May affect ability to drive & use machines. Moderate renal impairment. Avoid use during pregnancy. Not to be used during lactation. Childn <18 yr. Elderly >75 yr.
Adverse Reactions
Dizziness, headache; abdominal pain, diarrhoea, dyspepsia, nausea, vomiting; rash, pruritus, urticaria; asthenia.
MIMS Class
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Vastarel XR PR cap 80 mg
Packing/Price
10's;30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in